arginine vasopressin has been researched along with 6-ketoprostaglandin f1 alpha in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (60.87) | 18.7374 |
| 1990's | 5 (21.74) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dolci, W; Gerber-Wicht, C; Rivest, RW; Vallotton, MB | 1 |
| Dolci, W; Gerber-Wicht, C; Vallotton, MB; Wüthrich, RP | 1 |
| Blay, J; Hollenberg, MD | 1 |
| Dolci, W; Fischer, JA; Gerber-Wicht, C; Vallotton, MB | 1 |
| Düsing, R; Glänzer, K; Kramer, HJ; Landsberg, G; Scherf, H | 1 |
| Carrara, MC; McGiff, JC; McNeill, H; Miller, MJ; Westlin, WF | 1 |
| Barrow, SE; Dollery, CT; Heavey, DJ; Hickling, NE; Ritter, JM; Vial, J | 1 |
| McGiff, JC; McNeill, H; Miller, MJ; Westlin, WF | 1 |
| Bayorh, MA; Faden, AI; Feuerstein, G; Goldstein, DS; Ramwell, PW; Stull, R; Zerbe, RL | 1 |
| Aikawa, M; Dunn, M; Hassid, A; Pugliese, F; Sato, M; Williams, S | 1 |
| Barnhart, MI; Chen, S; Lusher, JM | 1 |
| Knop, J; Schmitz-Huebner, U | 1 |
| Cooper, CL; Malik, KU | 1 |
| Capitanio, A; D'Angelo, A; Mannucci, PM; Smith, JB; Valsecchi, C | 1 |
| Arant, BS; Engle, WD; Rosenfeld, CR; Wiriyathian, S | 1 |
| Shimizu, K | 1 |
| Stallone, JN | 1 |
| Beilin, LJ; Chu, ZM | 1 |
| Descomps, B; Lobaccaro-Henri, C; Thaler-Dao, H | 1 |
| Akishita, M; Ako, J; Eto, M; Hashimoto, M; Kozaki, K; Nagano, K; Ouchi, Y; Sudoh, N; Toba, K; Watanabe, T; Yoshizumi, M | 1 |
| Aloisi, C; Buemi, M; Corica, F; D'Anna, R; Di Pasquale, G; Floccari, F; Frisina, N; Leonardi, I; Ruello, A | 1 |
| Aloisi, C; Buemi, M; Corica, F; Corsonello, A; Di Pasquale, G; Floccari, F; Frisina, N; Latassa, G; Ruello, A; Sturiale, A | 1 |
| Beauregard, K; Bouvier, M; Brault, S; Chemtob, S; Duhamel, F; Gobeil, F; Guillon, G; Hamdan, FF; Hamel, D; Hardy, P; Heveker, N; Hou, X; Joyal, JS; Kaul, R; Lahaie, I; Lubell, WD; Nedev, H; Quiniou, C; Rihakova, L; Sapieha, P; Saragovi, HU; Shao, Z | 1 |
2 trial(s) available for arginine vasopressin and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Aquaretic effects of the nonpeptide V2 antagonist OPC-31260 in hydropenic humans.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aldosterone; Angiotensin II; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Calcium; Creatinine; Dinoprostone; Epinephrine; Heart Rate; Humans; Male; Norepinephrine; Osmolar Concentration; Phosphates; Potassium; Sodium; Thromboxane B2; Uric Acid; Urine; Water; Water Deprivation | 1995 |
Effect of a prostacyclin analogue, iloprost, on urinary aquaporin-2 excretion in humans.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Creatinine; Dinoprostone; Epoprostenol; Female; Humans; Iloprost; Male; Osmolar Concentration; Vasodilator Agents | 2002 |
21 other study(ies) available for arginine vasopressin and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Effect of different calcium channel blockers on angiotensin II- and vasopressin-induced prostacyclin biosynthesis in vascular smooth muscle cells.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Arginine Vasopressin; Calcium Channel Blockers; Cells, Cultured; Drug Interactions; Epoprostenol; Female; Muscle, Smooth, Vascular; Radioimmunoassay; Rats; Rats, Inbred Strains | 1990 |
Interaction of vasopressin and angiotensin II in stimulation of prostacyclin synthesis in vascular smooth muscle cells.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Arginine Vasopressin; Calcium; Calcium Channel Blockers; Cells, Cultured; Drug Interactions; Drug Synergism; Epoprostenol; Extracellular Space; Muscle, Smooth, Vascular; Stimulation, Chemical | 1989 |
Epidermal growth factor stimulation of prostacyclin production by cultured aortic smooth muscle cells: requirement for increased cellular calcium levels.
Topics: 6-Ketoprostaglandin F1 alpha; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Aorta; Arginine Vasopressin; Calcium; Calcium Channel Blockers; Calcium Chloride; Cell Line; Cyclic GMP; Epidermal Growth Factor; Gallic Acid; Kinetics; Muscle, Smooth, Vascular; Nifedipine; Tetradecanoylphorbol Acetate | 1989 |
Action of calcitonin gene-related peptide on rat aortic smooth muscle.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Aorta, Thoracic; Arginine Vasopressin; Calcitonin Gene-Related Peptide; Cells, Cultured; Colforsin; Cyclic AMP; Dinoprost; Dinoprostone; In Vitro Techniques; Muscle, Smooth, Vascular; Rats | 1989 |
Prostacyclin synthesis by isolated rat aorta: role of 8-arginine-vasopressin.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta, Abdominal; Arginine Vasopressin; Epoprostenol; Female; In Vitro Techniques; Rats; Rats, Inbred Strains | 1985 |
Compartmental prostaglandin release by angiotensin II and arginine-vasopressin in rabbit isolated perfused kidneys.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Arginine Vasopressin; Dinoprost; Dinoprostone; In Vitro Techniques; Kidney; Male; Muscle Contraction; Perfusion; Prostaglandins; Prostaglandins E; Prostaglandins F; Rabbits; Radioimmunoassay; Renal Circulation; Thromboxane B2 | 1986 |
Effect of vasoactive peptides on prostacyclin synthesis in man.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Angiotensin II; Arginine Vasopressin; Blood Pressure; Bradykinin; Deamino Arginine Vasopressin; Epoprostenol; Heart Rate; Humans; Male | 1986 |
Renal prostaglandin efflux induced by vasopressin, dDAVP and arachidonic acid: contrasting profile and sites of release.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acids; Arginine Vasopressin; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Kidney; Perfusion; Prostaglandins E; Prostaglandins F; Rabbits; Radioimmunoassay | 1986 |
Effects of nafazatrom on cardiovascular, sympathetic, and endocrine responses to hemorrhagic shock in conscious rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arginine Vasopressin; Blood Pressure; Epinephrine; Fibrinolytic Agents; Heart Rate; Male; Norepinephrine; Pyrazoles; Pyrazolones; Rats; Rats, Inbred Strains; Shock, Hemorrhagic; SRS-A; Thromboxane B2 | 1985 |
Rabbit and rat renal papillary collecting tubule cells in culture: the interactions of arginine vasopressin, prostaglandins, and cyclic AMP.
Topics: 6-Ketoprostaglandin F1 alpha; Adenylyl Cyclases; Animals; Arachidonic Acid; Arachidonic Acids; Arginine Vasopressin; Aspirin; Calcimycin; Cells, Cultured; Cyclic AMP; Dinoprost; Dinoprostone; Kidney Tubules; Kinetics; Prostaglandins; Prostaglandins E; Prostaglandins F; Rabbits; Rats | 1983 |
DDAVP: does the drug have a direct effect on the vessel wall?
Topics: 6-Ketoprostaglandin F1 alpha; Antigens; Arginine Vasopressin; Blood Vessels; Deamino Arginine Vasopressin; Epinephrine; Factor VIII; Humans; In Vitro Techniques; Microscopy, Electron, Scanning; Perfusion; Platelet Adhesiveness; Thromboxane B2; Umbilical Veins; von Willebrand Factor | 1983 |
Evidence for an endothelial cell dysfunction in association with Behçet's disease.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Arginine Vasopressin; Behcet Syndrome; Deamino Arginine Vasopressin; Endothelium; Factor VIII; Female; Fibrinolysis; Humans; Male; Middle Aged; Plasminogen Activators | 1984 |
Effect of glucocorticoids on vascular reactivity to vasoactive hormones in rat isolated kidney: lack of relationship to prostaglandins.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Arginine Vasopressin; Bradykinin; Dexamethasone; Dinoprostone; Glucocorticoids; In Vitro Techniques; Indomethacin; Kidney; Male; Norepinephrine; Perfusion; Prostaglandins; Prostaglandins E; Rats; Rats, Inbred Strains; Vasoconstriction | 1984 |
Effect of des-amino-D-arginine vasopressin (DDAVP) on plasma levels of platelet and endothelial cell release products.
Topics: 6-Ketoprostaglandin F1 alpha; Arginine Vasopressin; Blood Platelets; Deamino Arginine Vasopressin; Endothelium; Humans; Thromboxane B2; Thromboxanes; Time Factors | 1983 |
Diuresis and respiratory distress syndrome: physiologic mechanisms and therapeutic implications.
Topics: 6-Ketoprostaglandin F1 alpha; Arginine Vasopressin; Diuresis; Humans; Infant, Newborn; Infant, Premature, Diseases; Kidney; Prostaglandins E; Respiratory Distress Syndrome, Newborn | 1983 |
Mesenteric vascular responses to vasopressin during development of DOCA-salt hypertension in male and female rats.
Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Animals; Arginine Vasopressin; Blood Pressure; Desoxycorticosterone; Dinoprostone; Dose-Response Relationship, Drug; Female; Hypertension; In Vitro Techniques; Male; Prostaglandins; Rats; Rats, Sprague-Dawley; Reference Values; Sex Characteristics; Sodium, Dietary; Splanchnic Circulation | 1995 |
Mechanisms of vasodilatation in pregnancy: studies of the role of prostaglandins and nitric-oxide in changes of vascular reactivity in the in situ blood perfused mesentery of pregnant rats.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Arginine; Arginine Vasopressin; Blood Pressure; Electric Stimulation; Female; In Vitro Techniques; Indomethacin; Mesentery; Nitric Oxide; Nitroarginine; Norepinephrine; Pregnancy; Prostaglandins; Rats; Rats, Inbred WKY; Sympathetic Nervous System; Thromboxane B2; Vasodilation | 1993 |
RU 38486 inhibits intracellular calcium mobilization and PGI2 release from human myometrium: mechanisms of action.
Topics: 6-Ketoprostaglandin F1 alpha; Abortifacient Agents, Steroidal; Arginine Vasopressin; Calcium; Calcium Channel Blockers; Calcium-Transporting ATPases; Drug Synergism; Endoplasmic Reticulum; Enzyme Inhibitors; Epoprostenol; Female; Gallic Acid; Hormone Antagonists; Humans; Intracellular Fluid; Mifepristone; Muscle Relaxation; Myometrium; Nifedipine; Phosphatidylinositol Diacylglycerol-Lyase; Phosphoric Diester Hydrolases; Staurosporine; Structure-Activity Relationship; Thapsigargin; Uterine Contraction | 1996 |
Prostanoids regulate proliferation of vascular smooth muscle cells induced by arginine vasopressin.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta, Thoracic; Arginine Vasopressin; Cell Division; Cell Line; Cells, Cultured; Dinoprostone; DNA; Dose-Response Relationship, Drug; Embryo, Mammalian; Epoprostenol; Male; Muscle, Smooth, Vascular; Prostaglandins; Rats; Thromboxane B2 | 2000 |
Urinary excretion of aquaporin-2 water channel during pregnancy.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Atrial Natriuretic Factor; Creatinine; Female; Humans; Osmolar Concentration; Oxytocin; Postpartum Period; Pregnancy; Pregnancy Trimesters; Sodium; Urine | 2001 |
VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonist.
Topics: 6-Ketoprostaglandin F1 alpha; Allosteric Regulation; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Cell Line; Cyclic AMP; Deamino Arginine Vasopressin; Diuresis; Dose-Response Relationship, Drug; Female; Hormone Antagonists; Humans; In Vitro Techniques; Ligands; Male; Mice; Muscle Relaxation; Muscle, Smooth; Myometrium; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Recombinant Fusion Proteins; Signal Transduction; Transfection; Urinary Bladder | 2009 |